Sensitizing Mucoepidermoid Carcinomas To Chemotherapy By Targeted Disruption Of Cancer Stem Cells

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES)Mucoepidermoid carcinoma (MEC) is the most common malignancy of salivary glands. The response of MEC to chemotherapy is unpredictable, and recent advances in cancer biology suggest the involvement of cancer stem cells (CSCs) in tumor progression and chemoresistance and radioresistance phenotype. We found that histone acetyltransferase inhibitors (HDACi) were capable of disrupting CSCs in MEC. Furthermore, administration of HDACi prior to Cisplatin (two-hit approach) disrupts CSCs and sensitizes tumor cells to Cisplatin. Our findings corroborate to emerging evidence that CSCs play a key role in tumor resistance to chemotherapy, and highlights a pharmacological two-hit approach that disrupts tumor resistance to conventional therapy.7274244742460University of MichiganNIH/NIDCR [R01-DE23220, R01-DE21139]CAPES (Coordination for the Improvement of Higher Education Personnel)Coordenação de Aperfeiçoamento de Pessoal de Nível Superior (CAPES